Kaoru Ichiki
Overview
Explore the profile of Kaoru Ichiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ueda T, Nakajima K, Ichiki K, Ishikawa K, Yamada K, Tsuchida T, et al.
Mycoses
. 2024 Jul;
67(7):e13771.
PMID: 39031945
Background: Acute kidney injury (AKI) and hypokalaemia are common adverse events after treatment with liposomal amphotericin B (L-AMB). Objectives: Because excess potassium (K) leakage occurs during renal tubular injury caused...
2.
Otani N, Nakajima K, Yamada K, Ishikawa K, Ichiki K, Ueda T, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932313
Assessment of the immune response to influenza vaccines should include an assessment of both humoral and cell-mediated immunity. However, there is a lack of consensus regarding the timing of immunological...
3.
Kunishima H, Ichiki K, Ohge H, Sakamoto F, Sato Y, Suzuki H, et al.
J Infect Chemother
. 2024 May;
30(8):673-715.
PMID: 38714273
No abstract available.
4.
Ueda T, Takesue Y, Nakajima K, Ichiki K, Ishikawa K, Yamada K, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839839
Increased antibiotic use and antibiotic homogeneity cause selective pressure. This study investigated the correlation between antibiotic diversity and antimicrobial resistance (AMR) in Gram-negative organisms. The days of therapy/100 patient-days (DOT)...
5.
Otani N, Nakajima K, Ishikawa K, Ichiki K, Yoda Y, Ueda T, et al.
Viruses
. 2022 Jul;
14(7).
PMID: 35891435
In Japan, inactivated influenza vaccines are used. We measured titers of antibodies to vaccine strains of three influenza types-influenza A (H1N1), influenza A (H3N2), and influenza B/Victoria-from the 2017/2018 to...
6.
Ueda T, Nakajima K, Ichiki K, Ishikawa K, Yamada K, Tsuchida T, et al.
J Infect Chemother
. 2022 Apr;
28(7):1023-1028.
PMID: 35477667
Introduction: Because of thrombocytopenia, linezolid treatment tends to be stopped before the completion of therapy for complicated infections that require prolonged antimicrobial administration. In contrast, tedizolid shows a favorable hematologic...
7.
Uchino M, Ikeuchi H, Horio Y, Kuwahara R, Minagawa T, Kusunoki K, et al.
Int J Colorectal Dis
. 2022 Apr;
37(5):999-1010.
PMID: 35384495
Purpose: We evaluated the influence of preoperative treatments with biologics on surgical morbidity in patients with Crohn's disease (CD). Methods: We reviewed the surveillance data of patients with CD who...
8.
Ueda T, Takesue Y, Nakajima K, Ichiki K, Ishikawa K, Yamada K, et al.
Antibiotics (Basel)
. 2022 Jan;
11(1).
PMID: 35052972
Area under the concentration-time curve (AUC)-guided vancomycin treatment is associated with decreased nephrotoxicity. It is preferable to obtain two samples to estimate the AUC. This study examined the usefulness of...
9.
Ueda T, Takesue Y, Nakajima K, Ichiki K, Ishikawa K, Yamada K, et al.
J Infect Chemother
. 2021 Nov;
28(2):232-237.
PMID: 34844858
Introduction: Because of its lower risk of renal toxicity than vancomycin, teicoplanin is the preferred treatment for methicillin-resistant Staphylococcus aureus infection in patients undergoing continuous venovenous haemodiafiltration (CVVHDF) in whom...
10.
Otani N, Nakajima K, Ishikawa K, Ichiki K, Ueda T, Takesue Y, et al.
Viruses
. 2021 Jul;
13(6).
PMID: 34199161
Interferon gamma (IFN-γ) is considered a key moderator of cell-mediated immunity. However, little is known about its association with granzyme B, which plays an important role in the effector function...